Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Carried Interest Fairness Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2022 · fourth_quarter · Q4
Issues related to diversity and inclusion in the venture capital workforce.
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Source: Senate LDA
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.
Carried Interest Fairness Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Carried Interest Fairness Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Carried Interest Fairness Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.
Next Generation Entrepreneurship Corps Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Next Generation Entrepreneurship Corps Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Next Generation Entrepreneurship Corps Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.
Next Generation Entrepreneurship Corps Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.
Next Generation Entrepreneurship Corps Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
National Science Foundation for the Future Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
National Science Foundation for the Future Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
National Science Foundation for the Future Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
National Science Foundation for the Future Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.
National Science Foundation for the Future Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Endless Frontier Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Endless Frontier Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Endless Frontier Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
Endless Frontier Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.
Endless Frontier Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
Helping Startups Continue To Grow Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301.
Helping Startups Continue To Grow Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act; Digital Commodities Consumer Protection Act S.4760/H.R.8730; foreign outbound investment restrictions.
Helping Startups Continue To Grow Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301.
Helping Startups Continue To Grow Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
Helping Startups Continue To Grow Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Infrastructure Investment and Jobs Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Infrastructure Investment and Jobs Act H.R.3684.
Platform Competition and Opportunity Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Platform Competition and Opportunity Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Platform Competition and Opportunity Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Platform Competition and Opportunity Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Platform Competition and Opportunity Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Ensuring Patient Access to Critical Breakthrough Products Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
To require the Securities and Exchange Commission to revise the definition of a qualifying investment to include an equity security issued by a qualifying portfolio company, whether acquired directly from the company or in a secondary acquisition, for purposes of the exemption from registration for venture capital fund advisers under the Investment Advisers Act of 1940, and for other purposes.
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301.
To require the Securities and Exchange Commission to revise the definition of a qualifying investment to include an equity security issued by a qualifying portfolio company, whether acquired directly from the company or in a secondary acquisition, for purposes of the exemption from registration for venture capital fund advisers under the Investment Advisers Act of 1940, and for other purposes.
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
To require the Securities and Exchange Commission to revise the definition of a qualifying investment to include an equity security issued by a qualifying portfolio company, whether acquired directly from the company or in a secondary acquisition, for purposes of the exemption from registration for venture capital fund advisers under the Investment Advisers Act of 1940, and for other purposes.
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301.
To require the Securities and Exchange Commission to revise the definition of a qualifying investment to include an equity security issued by a qualifying portfolio company, whether acquired directly from the company or in a secondary acquisition, for purposes of the exemption from registration for venture capital fund advisers under the Investment Advisers Act of 1940, and for other purposes.
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act; Digital Commodities Consumer Protection Act S.4760/H.R.8730; foreign outbound investment restrictions.
To require the Securities and Exchange Commission to revise the definition of a qualifying investment to include an equity security issued by a qualifying portfolio company, whether acquired directly from the company or in a secondary acquisition, for purposes of the exemption from registration for venture capital fund advisers under the Investment Advisers Act of 1940, and for other purposes.
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
Improving Capital Allocation for Newcomers Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
Improving Capital Allocation for Newcomers Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
Improving Capital Allocation for Newcomers Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act; Digital Commodities Consumer Protection Act S.4760/H.R.8730; foreign outbound investment restrictions.
Chips and Science Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Chips and Science Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.
Chips and Science Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
United States Innovation and Competition Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
United States Innovation and Competition Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.
United States Innovation and Competition Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
United States Innovation and Competition Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
United States Innovation and Competition Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
LIKE Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
LIKE Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
LIKE Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
LIKE Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
LIKE Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
Micro-SBIC and Emerging Managers Program Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.
Micro-SBIC and Emerging Managers Program Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.
Micro-SBIC and Emerging Managers Program Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Micro-SBIC and Emerging Managers Program Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Micro-SBIC and Emerging Managers Program Act of 2021
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Inflation Reduction Act of 2022
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
ARPA–H Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
ARPA–H Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
ARPA–H Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
ARPA–H Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
ARPA–H Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Cures 2.0 Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Cures 2.0 Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Cures 2.0 Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Cures 2.0 Act
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: NATIONAL VENTURE CAPITAL ASSOCIATION
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act; Digital Commodities Consumer Protection Act S.4760/H.R.8730; foreign outbound investment restrictions.
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346; CHIPS and Science Act H.R.4346 program appropriations.
Monitor updated export control regulations; National Critical Capabilities Defense Act S.1854
Intellectual property issues that impact startups.
Infrastructure Investment and Jobs Act H.R.3684.
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2022 · third_quarter · 3A
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Monitor updated export control regulations; National Critical Capabilities Defense Act S.1854
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Issues related to diversity and inclusion in the venture capital workforce.
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
Intellectual property issues that impact startups.
Infrastructure Investment and Jobs Act H.R.3684.
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2022 · third_quarter · Q3
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
Issues related to diversity and inclusion in the venture capital workforce.
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301; S. 3976, Expanding American Entrepreneurship Act; H.R. 4243, Improving Capital Allocation for Newcomers Act; S. 4857, Private Markets Transparency and Accountability Act.
Climate and sustainability policy issues, including energy tax issues; ARPA-E; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Ending the Carried Interest Loophole Act S.2617.
Intellectual property issues that impact startups.
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759; SBIR and STTR Extension Act of 2022 S.4900.
Monitor updated export control regulations; National Critical Capabilities Defense Act S.1854
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; Inflation Reduction Act (HR 5376) Public Law No. 117-169.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521; CHIPS and Science Act H.R.4346.
Infrastructure Investment and Jobs Act H.R.3684.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2022 · second_quarter · Q2
Infrastructure Investment and Jobs Act H.R.3684.
Intellectual property issues that impact startups.
Issues related to diversity and inclusion in the venture capital workforce.
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; implementation issues around the Infrastructure Investment and Jobs Act H.R.3684.
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.
Engagement with SEC on regulatory proposals including Special Purpose Acquisition Companies, Shell Companies, and Projections proposal, Private Fund Advisers, Documentation of Registered Investment Adviser Compliance Reviews proposal, Rule 10b5-1 and Insider Trading proposal, Amendments to Form PF to Require Current Reporting and Amend Reporting Requirements for Large Private Equity Advisers and Large Liquidity Fund Advisers proposal, and Modernization of Beneficial Ownership Reporting proposal; Small capitalization company capital formation issues; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301.
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act H.R.7503; Start-ups for Cures Act H.R.7504; More Cures Act H.R.7505; Fostering Innovation and Research to Strengthen Tomorrow (FIRST) Act H.R. 8253; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
Monitor updated export control regulations; National Critical Capabilities Defense Act S.1854
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2022 · first_quarter · Q1
Monitor updated export control regulations; National Critical Capabilities Defense Act S.1854
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585.
Infrastructure Investment and Jobs Act H.R.3684.
Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act S.3914/H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act H.R.3448; JOBS Act 4.0; Sherman amendment, Sec. 61301.
Intellectual property issues that impact startups.
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.
Issues related to diversity and inclusion in the venture capital workforce.
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684; America COMPETES Act, H.R.4521.
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197.
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759.
Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684.
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2021 · fourth_quarter · Q4
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Cures 2.0 Act H.R.6000; Proposals for Advanced Research Project Agency- Health: ARPA-H Act, H.R.5585
Intellectual property issues that impact startups;
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Qualified Small Business Stock; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2021 · third_quarter · Q3
Intellectual property issues that impact startups;
Infrastructure Investment and Jobs Act H.R.3684.
Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act H.R.3448;
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2021 · second_quarter · Q2
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Opportunity and Competition Act HR 3826
Startup visa; international entrepreneur rule;STEM visas
Endless Frontier Act HR 2731; US Innovation & Competition Act S 1260; Basic research funding and technology commercialization issues; NSF for the Future Act HR 2225
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2021 · first_quarter · Q1
SBIR/STTR programs;Next Generation Entrepreneurship Corps Act S 389/HR 1226;
Intellectual property issues that impact startups;
Capital gains tax policy, including carried interest; Carried Interest Fairness Act HR 1068; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2020 · fourth_quarter · Q4
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019; Endless Frontier Act S. 3832/ H.R. 6978
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543
Startup Act S. 328; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; Comprehensive Immigration Reform; International Entrepreneur Rule
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2020 · third_quarter · Q3
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Main Street Loan Program.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2020 · second_quarter · Q2
Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act
Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2020 · first_quarter · Q1
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196
Issues related to the Tax Cuts ands Jobs Act; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Request to allow electronic 83(b) filings;
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2019 · fourth_quarter · Q4
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918
Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2019 · third_quarter · Q3
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2019 · second_quarter · Q2
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act;
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2019 · first_quarter · Q1
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019
Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act;
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2018 · fourth_quarter · Q4
Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.
Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2018 · third_quarter · Q3
Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.
Basic science research funding and tech transfer issues, Innovators to Entrepreneurs Act H.R. 5086.
Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2018 · second_quarter · Q2
Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390/H.R. 5340.
Small company capital formation issues, capital markets reform to encourage more US IPOs; H.R. 5054 the Small Company Disclosure Simplification Act, H.R. 5756 to require the SEC to adjust resubmission thresholds for shareholder proposals, H.R. 5970 Modernizing Disclosures for Investors Act, H.R. 6130 Helping Startups Continue to Grow Act, H.R. 6139 Improving Investment Research for Small and Emerging Issuers Act, Proposals to expand the definition of smaller reporting company (SRC),Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker Rule, Registered Investment Advisor rules, the Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 6177, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, Corporate Governance Reform and Transparency Act H.R. 4015, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act S. 2098/H.R. 4311, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, cryptocurrency regulation, and House Innovation Initiative.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2018 · first_quarter · Q1
Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390/H.R. 5340.
Small company capital formation issues, capital markets reform to encourage more US IPOs; Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, Corporate Governance Reform and Transparency Act H.R. 4015, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act S. 2098/H.R. 4311, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, cryptocurrency regulation, and House Innovation Initiative.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2017 · fourth_quarter · Q4
Basic science research funding and tech transfer issues.
Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.
Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2017 · third_quarter · Q3
Small company capital formation issues, capital markets reform to encourage more US IPOs; Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act, and House Innovation Initiative.
Various patent litigation reforms that impact investment in the start-up ecosystem; stronger patents act.
Basic science research funding and tech transfer issues.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2017 · second_quarter · Q2
Tax reform, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options.
Basic science research funding and tech transfer issues.
Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2017 · first_quarter · Q1
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Drug pricing issues, the Promises for Antibiotics and Therapeutics for Health Act, proposals to create limited use pathways for certain drugs, CMS reimbursement policy, Medical Device User Fee Act reauthorization, Prescription Drug User Fee Act reauthorization.
Various patent litigation reforms that impact investment in the start-up ecosystem.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2016 · fourth_quarter · 4A
Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.
Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; and Comprehensive Immigration Reform.
Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act, augmented reality.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2016 · second_quarter · 2A
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
21st Century Cures Initiative, drug pricing issues, S. 185 the Promises for Antibiotics and Therapeutics for Health Act and proposals to create limited use pathways for certain drugs, CMS reimbursement.
Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2016 · fourth_quarter · Q4
Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act, augmented reality.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2016 · third_quarter · Q3
21st Century Cures Initiative, drug pricing issues, the Promises for Antibiotics and Therapeutics for Health Act (S.185), proposals to create limited use pathways for certain drugs, CMS reimbursement.
Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration. EB-5 Visa, and Comprehensive Immigration Reform.
Basic science research funding and tech transfer issues.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2016 · second_quarter · Q2
Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act.
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Basic science research funding and tech transfer issues.
NATIONAL VENTURE CAPITAL ASSOCIATION via NATIONAL VENTURE CAPITAL ASSOCIATION
2016 · first_quarter · Q1
21st Century Cures Initiative, drug pricing issues, S. 185 the Promises for Antibiotics and Therapeutics for Health Act and proposals to create limited use pathways for certain drugs, CMS reimbursement.
Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and RAISE Act.
Cybersecurity issues, privacy and information sharing issues and Net Neutrality, Internet Tax Freedom Act.
Infrastructure Investment and Jobs Act H.R.3684.
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759
Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684.
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Competition and Opportunity Act H.R.3826/S.3197
Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Revising the SEC definition of venture capital fund/DEAL Act H.R.4227; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act H.R.3448;
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R. 3684.
Let Immigrants Kickstart Employment Act H.R. 4681; international entrepreneur rule
Issues related to diversity and inclusion in the venture capital workforce
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Capital gains tax policy, including carried interest; Carried Interest Fairness Act H.R.1068/S.1598; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S.1288; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Ending the Carried Interest Loophole Act S.2617.
Endless Frontier Act H.R.2731; US Innovation & Competition Act S.1260; Basic research funding and technology commercialization issues; NSF for the Future Act H.R.2225; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R. 3684.
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA); Platform Opportunity and Competition Act H.R.3826
Climate and sustainability policy issues, including energy tax issues; ARPA-E; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.; Infrastructure Investment and Jobs Act H.R.3684.
Startup visa; international entrepreneur rule; STEM visas
SBIR/STTR programs; Next Generation Entrepreneurship Corps Act S.389/H.R.1226; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14; Micro-SBIC and Emerging Managers Program Act H.R.5225/S.1759
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act H.R.4043; the Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Climate and sustainability policy issues, including energy tax issues; ARPA-E;
Capital gains tax policy, including carried interest; Carried Interest Fairness Act HR 1068/S 1598; Stock options; Partnership tax policy; Section 1202; Tax assets issues including net operating loss carryforwards and R&D credit; IGNITE American Innovation Act; American Innovation & Jobs Act; American Innovation Act; Climate and energy tax issues, including production and investment tax credits and Section 45Q; GREEN Act; American Jobs in Energy Manufacturing Act of 2021; Clean Energy for America Act S 1288
Intellectual property issues that impact startups;
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; Ensuring Patient Access to Critical Breakthrough Products Act HR 4043;
Small capitalization company capital formation issues; Special Purpose Acquisition Companies; Disclosure of material short positions; Issues related to improving research coverage for small companies; Volcker Rule; Revising the SEC definition of venture capital fund/DEAL Act; Implementation of the Foreign Investment Risk Review Modernization Act; Blockchain regulatory and policy issues including the Token Taxonomy Act; Beneficial ownership rules implementation; Helping Startups Continue to Grow Act HR 3448;
SBIR/STTR programs;Next Generation Entrepreneurship Corps Act S 389/HR 1226;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Startup visa; international entrepreneur rule;STEM visas
Antitrust and competition policy impacting startups; Competition and Antitrust Law Enforcement Act of 2021 (CALERA)
Endless Frontier Act; Basic research funding and technology commercialization issues; NSF for the Future Act
Climate and sustainability policy issues, including energy tax issues; ARPA-E;
Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology;
Small capitalization company capital formation issues; Special Purpose Acquisition Companies; disclosure of material short positions; issues related to improving research coverage for small companies; Volcker Rule; Revising the SEC definition of venture capital fund/DEAL Act; Implementation of the Foreign Investment Risk Review Modernization Act; blockchain regulatory and policy issues including the Token Taxonomy Act, including FinCEN rule regarding convertible virtual currencies; beneficial ownership rules implementation; Helping Startups Continue to Grow Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Paycheck Protection Program (PPP)
Issues related to the Tax Cuts and Jobs Act; Section 1061 regulations; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Issues related to the Phase IV economic relief package including monetization of tax assets for growth companies and the employee retention tax credit; IGNITE American Innovation Act HR 7917; HEROES Act HR 6800; Tax bills to encourage American innovation and medical independence, HRs 7766, 7505, 7556; American Innovation and Jobs Act S. 4822
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144 and FinCEN rule regarding convertible virtual currencies; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 8603; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Main Street Loan Program.
Cybersecurity; data privacy issues; Net Neutrality; fintech; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Financial Crimes Enforcement Network (FinCEN), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Issues related to the Tax Cuts ands Jobs Act; Section 1061 regulations; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Issues related to the Phase IV economic relief package including monetization of tax assets for growth companies and the employee retention tax credit; IGNITE American Innovation Act HR 7917; HEROES Act HR 6800; Tax bills to encourage American innovation and medical independence, HRs 7766, 7505, 7556
Cybersecurity; data privacy issues; Net Neutrality; fintech; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Paycheck Protection Program (PPP)
Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; Comprehensive Immigration Reform; International Entrepreneur Rule
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019; Endless Frontier Act S. 3832/ H.R. 6978
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Paycheck Protection Program (PPP)
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196
Issues related to the Tax Cuts ands Jobs Act; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Issues related to the Phase IV economic relief package including monetization of tax assets for growth companies and the employee retention tax credit.
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Request to temporarily waive notarization requirements for Form ID filings during COVID-19 crisis; Request to allow flexibility in custody rule during COVID-19 crisis; Main Street Loan Program.
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019; Endless Frontier Act S. 3832/ H.R. 6978
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups
Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Request to temporarily waive notarization requirements for Form ID filings during COVID-19 crisis; Request to allow flexibility in custody rule during COVID-19 crisis
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196
Issues related to the Tax Cuts ands Jobs Act; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act
Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule
Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups
Issues related to the Tax Cuts ands Jobs Act; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues; Research & Development Tax Credit Expansion Act, S. 2207
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs;
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019
Issues related to the Tax Cuts ands Jobs Act; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations
Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking
Startup Act; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform; International Entrepreneur Rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Issues related to the Tax Cuts ands Jobs Act; Carried Interest Fairness Act, H.R. 1735/S. 781; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, energy innovation tax issues
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs;
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy
Cybersecurity; data privacy issues; Net Neutrality; fintech; FirstNet; Emerging and foundational technologies rulemaking
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Basic science research funding and tech transfer issues, Innovators to Entrepreneurs Act H.R. 5086.
H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382 including H.R. 6756 the American Innovation Act, medical device tax repeal, tax extenders, energy innovation tax issues, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444, Retirement, Savings, and Other Tax Relief Act of 2018, H.R. 88.
Small company capital formation issues, capital markets reform to encourage more US IPOs, JOBS and Investor Confidence Act, H.R. 5054 the Small Company Disclosure Simplification Act, H.R. 5756 to require the SEC to adjust resubmission thresholds for shareholder proposals, H.R. 5970 Modernizing Disclosures for Investors Act, H.R. 6130 Helping Startups Continue to Grow Act, H.R. 6139 Improving Investment Research for Small and Emerging Issuers Act, Proposals to expand the definition of smaller reporting company (SRC),Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker Rule, Registered Investment Advisor rules, the Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 6177/S. 3575, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, Corporate Governance Reform and Transparency Act H.R. 4015, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act S. 2098/H.R. 4311, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, cryptocurrency regulation, and House Innovation Initiative.
Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390/H.R. 5340.
Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.
Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.
Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390/H.R. 5340.
Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Tax reform, H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382 including H.R. 6756 the American Innovation Act, medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444.
Small company capital formation issues, capital markets reform to encourage more US IPOs, JOBS and Investor Confidence Act, H.R. 5054 the Small Company Disclosure Simplification Act, H.R. 5756 to require the SEC to adjust resubmission thresholds for shareholder proposals, H.R. 5970 Modernizing Disclosures for Investors Act, H.R. 6130 Helping Startups Continue to Grow Act, H.R. 6139 Improving Investment Research for Small and Emerging Issuers Act, Proposals to expand the definition of smaller reporting company (SRC),Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker Rule, Registered Investment Advisor rules, the Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 6177, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, Corporate Governance Reform and Transparency Act H.R. 4015, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act S. 2098/H.R. 4311, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, cryptocurrency regulation, and House Innovation Initiative.
Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.
Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.
Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Basic science research funding and tech transfer issues, Innovators to Entrepreneurs Act H.R. 5086.
Tax reform, H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444.
Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.
Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Federal Communications Commission (FCC), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.
Small business issues, Small Business Administration 8(a) & 8(m) programs, SBIR/STTR programs, H.R. 2763 SBIR/STTR Improvements Act of 2017.
Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.
Basic science research funding and tech transfer issues, Innovators to Entrepreneurs Act H.R. 5086.
Tax reform, H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444.
Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.
Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Tax reform, H.R. 1/Tax Cuts and Jobs Act, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options, Empowering Employees through Stock Ownership Act H.R. 3084/S. 1444.
Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.
Various patent litigation reforms that impact investment in the start-up ecosystem; Stronger Patents Act S. 1390.
Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.
Small company capital formation issues, capital markets reform to encourage more US IPOs; Disclosure of material short positions, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, Fostering Innovation Act H.R. 4139/S. 1645, H.R. 4015 Corporate Governance Reform and Transparency Act, beneficial ownership disclosure rules/Counterterrorism & Illicit Finance Act, Foreign Investment Risk Review Modernization Act, Economic Growth, Regulatory Relief, and Consumer Protection Act S. 2155, and House Innovation Initiative.
Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), Treasury, Dept of, White House Office
Tax reform, carried interest capital gains tax policy, partnership tax rules, tax policy that encourages new company formation including: Section 1202, Section 382, Medical device tax repeal, tax extenders, energy innovation tax issues, R&D credit, stock options.
Startup Act (Startup Visa); Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; Comprehensive Immigration Reform and International Entrepreneur Rule.
Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Cybersecurity, privacy and information sharing issues, Net Neutrality, augmented reality, Fintech, FirstNet.
Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy; Medical Device User Fee Act reauthorization; Prescription Drug User Fee Act reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Various patent litigation reforms that impact investment in the start-up ecosystem.
Drug pricing, the Promises for Antibiotics and Therapeutics for Health Act, proposals to create limited use pathways for certain drugs, CMS reimbursement policy, Medical Device User Fee Act reauthorization, Prescription Drug User Fee Act reauthorization.
Cybersecurity, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act, augmented reality, Fintech, FirstNet.
Cleantech and Energy Policy Issues, new Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Small company capital formation issues, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Basic science research funding and tech transfer issues.
Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; and Comprehensive Immigration Reform.
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202 startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform, R&D credit, stock options.
Small company capital formation issues, Dodd-Frank regulatory issues, Volcker rule, Registered Investment Advisor rules, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.
Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act, augmented reality.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform, R&D credit.
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
21st Century Cures Initiative, drug pricing issues, the Promises for Antibiotics and Therapeutics for Health Act (S.185), proposals to create limited use pathways for certain drugs, CMS reimbursement.
Various patent litigation reforms that impact investment in the start-up ecosystem, including H.R. 9, S.1137, the TROL Act, and STRONG Patents Act.
Basic science research funding and tech transfer issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Basic science research funding and tech transfer issues.
Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration. EB-5 Visa, and Comprehensive Immigration Reform.
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.
Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.
Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act, STRONG Patents Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform, R&D credit.
Various patent litigation reforms that impact investment in the start-up ecosystem, including H.R. 9, S.1137, the TROL Act, and STRONG Patents Act.
Basic science research funding and tech transfer issues.
Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration; EB-5 Visa; and Comprehensive Immigration Reform.
21st Century Cures Initiative, drug pricing issues, the Promises for Antibiotics and Therapeutics for Health Act (S.185), proposals to create limited use pathways for certain drugs, CMS reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Cybersecurity issues, privacy and information sharing issues, Net Neutrality, Internet Tax Freedom Act.
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.
Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.
Various patent litigation reforms that impact investment in the start-up ecosystem, including H.R. 9, S.1137, the TROL Act, and STRONG Patents Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Small company capital formation issues, Dodd-Frank regulatory issues, Implementation of JOBS Act, Tick Size Pilot, venture exchanges, HALOs Act, creation of Office of SEC Small Business Advocate and Fostering Innovation Act, and House Innovation Initiative.
Startup Act (Startup Visa); Invest Visa, Entrepreneurial Visa; Executive Order on Immigration. EB-5 Visa, and Comprehensive Immigration Reform.
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.
Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act, STRONG Patents Act.
21st Century Cures Initiative, drug pricing issues, S. 185 the Promises for Antibiotics and Therapeutics for Health Act and proposals to create limited use pathways for certain drugs, CMS reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Lobbied Congress on various patent litigation reforms that impact investment in the start-up ecosystem including H.R. 9, S.1137 the TROL Act, STRONG Patents Act.
Basic science research funding and tech transfer issues.
Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; Energy and Water Appropriations.
Startup VISA Act; Invest VISA, Entrepreneurial VISA; Executive Order on Immigration. EB5 Visa.
Tax reform, carried interest, capital gains tax policy, partnership tax rules, 1202, startup and small business tax proposals, medical device tax repeal, tax extenders, energy innovation tax, Section 382 NOL Reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Science & Technology Policy (OSTP), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office